Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): A randomised open-label phase 2 study

Jorge Cortes, Eric Feldman, Karen Yee, David Rizzieri, Anjali S. Advani, Anthony Charman, Richard Spruyt, Martin Toal, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): A randomised open-label phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences